Hermes J Florez

Professor

  • 3401 Citations
19952019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hermes J Florez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

GENERAL CLINICAL RESEARCH CENTER

Alejandro, R., Saab, P., Weiss, S. M., Antoni, M. H., Feaster, D. J., Florez, H. J., Schneiderman, N., Hurwitz, B., Clarkson, J., Goldberg, R., Penedo, F., Elsas, L., Goldschmidt-Clermont, P., Ramsey, R. E., Scott, G. B., Levis, S., Berkovitz, G. D., Miguez, M., Haslett, P. A. J., Sipski, M., Marks, J., Goodkin, K., Ramsay, E., Jayaraman, S., Hoffman, R. W., Duara, S., Bandstra, E. S., Nash, M. S. & Scott, G. B.

National Institutes of Health

8/15/029/30/07

Project: Research project

Research Output

Baseline characteristics of randomized participants in the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE)

Wexler, D. J., Krause-Steinrauf, H., Crandall, J. P., Florez, H. J., Hox, S. H., Kuhn, A., Sood, A., Underkofler, C. & Aroda, V. R., Nov 1 2019, In : Diabetes care. 42, 11, p. 2098-2107 10 p.

Research output: Contribution to journalArticle

Open Access
  • 3 Scopus citations

    Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

    REWIND Investigators, Jul 13 2019, In : The Lancet. 394, 10193, p. 121-130 10 p.

    Research output: Contribution to journalArticle

  • 190 Scopus citations

    Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

    REWIND Investigators, Jul 13 2019, In : The Lancet. 394, 10193, p. 131-138 8 p.

    Research output: Contribution to journalArticle

  • 56 Scopus citations

    Erratum: A randomized controlled trial comparing efficacy and safety of insulin glargine 300 units/mL versus 100 units/mL in older people with type 2 diabetes: Results from the SENIOR study. (Diabetes care (2018) 41(1672-1680)DOI: 10.2337/dc09-19er08)

    Ritzel, R., Harris, S. B., Baron, H., Florez, H., Roussel, R., Espinasse, M., Muehlen-Bartmer, I., Zhang, N., Bertolini, M., Brulle-Wohlhueter, C., Munshi, M. & Bolli, G. B., Aug 1 2019, In : Diabetes care. 42, 8, 1 p.

    Research output: Contribution to journalComment/debate

  • Gender Differences in Demographic and Health Characteristics of the Million Veteran Program Cohort

    VA Million Veteran Program, Jun 25 2019, In : Women's Health Issues. 29, p. S56-S66

    Research output: Contribution to journalArticle

  • 2 Scopus citations